SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Balaxi Pharmaceuticals gets nod to invest up to $4 million in Balaxi Global FZCO

12 Nov 2025 Evaluate

Balaxi Pharmaceuticals has received approval to invest up to $4 million as equity in its wholly owned subsidiary i.e Balaxi Global FZCO (Formerly known as Balaxi Global DMCC), Dubai. The objective for investment in WOS is to extend support for operational and business expansion requirements. The proposed investment would be completed on or before March 31, 2026.

The Board of Directors of the company, in their meeting held on November 11, 2025, has approved the same.

Balaxi Pharmaceuticals is engaged in the business of international wholesale trading of Pharmaceuticals, Builders Hardware and FMCG products.


Peers
Company Name CMP
Redington 225.05
Adani Enterprises 2145.20
Amrapali Industries 17.95
Rashi Peripheral 440.00
PDS 302.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×